Barnett et al. found that Black people and other racialised groups in the U.S. are less likely to obtain prescriptions for buprenorphine, naloxone and benzodiazepines than their white counterparts.
EHRA publish their latest edition of CHECK magazine, focusing on the disproportionate levels of stigmatisation and discrimination that women who use drugs face as a result of existing gender inequalities and prohibitionist policies.
The Civic Futures Initiative explore (among other 'wars') the impact that Duterte’s oppressive and securitised 'war on drugs' in the Philippines had on the civic space of those who advocate against the drug policy and document abuses under it.
Rhodes and Lancaster argue that state responses to drug deaths crises rarely account for the long-term causes that push people who use drugs into premature death.
Sypsa et al. highlight the efficacy of peer-driven programmes to early identify a localised HIV outbreak and to implement health responses to mitigate it.
Mclauchlan et al. explore the recurrence of politicians expressing support for drug policy reform only after leaving office, signalling a need for a closer look into the factors that influence public support for reform among lawmakers.
C-EHRN discuss how integrated and person centred-care means putting people and communities, not diseases, at the centre of health systems and empowering people to take charge of their own health.
Cat Packer highlights how the Biden administration could use existing norms on equity as a framework to understand and address how cannabis laws and policies create barriers for underserved communities.
